DE602006017199D1 - Hemmung reaktiver sauerstoffspezies und schutz von säugerzellen - Google Patents

Hemmung reaktiver sauerstoffspezies und schutz von säugerzellen

Info

Publication number
DE602006017199D1
DE602006017199D1 DE602006017199T DE602006017199T DE602006017199D1 DE 602006017199 D1 DE602006017199 D1 DE 602006017199D1 DE 602006017199 T DE602006017199 T DE 602006017199T DE 602006017199 T DE602006017199 T DE 602006017199T DE 602006017199 D1 DE602006017199 D1 DE 602006017199D1
Authority
DE
Germany
Prior art keywords
oxygen species
reactive oxygen
ros
protection
mammalian cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006017199T
Other languages
English (en)
Inventor
Sudipta Seal
Swanand Patil
Steve Sezate
Lily Wong
Junping Chen
James F Mcginnis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Central Florida Research Foundation Inc UCFRF
Original Assignee
University of Central Florida Research Foundation Inc UCFRF
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Central Florida Research Foundation Inc UCFRF filed Critical University of Central Florida Research Foundation Inc UCFRF
Publication of DE602006017199D1 publication Critical patent/DE602006017199D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/244—Lanthanides; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE602006017199T 2005-04-29 2006-04-27 Hemmung reaktiver sauerstoffspezies und schutz von säugerzellen Active DE602006017199D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US67604305P 2005-04-29 2005-04-29
US71663005P 2005-09-13 2005-09-13
PCT/US2006/016050 WO2006118954A2 (en) 2005-04-29 2006-04-27 Inhibition of reactive oxygen species and protection of mammalian cells

Publications (1)

Publication Number Publication Date
DE602006017199D1 true DE602006017199D1 (de) 2010-11-11

Family

ID=37308499

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006017199T Active DE602006017199D1 (de) 2005-04-29 2006-04-27 Hemmung reaktiver sauerstoffspezies und schutz von säugerzellen

Country Status (7)

Country Link
US (2) US7727559B2 (de)
EP (2) EP2359907A1 (de)
AT (1) ATE482748T1 (de)
AU (1) AU2006242541B2 (de)
CA (1) CA2610296C (de)
DE (1) DE602006017199D1 (de)
WO (1) WO2006118954A2 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110111007A1 (en) * 2005-04-29 2011-05-12 Mcginnis James F Inhibition of retinal cell degeneration or neovascularization by cerium oxide nanoparticles
JP2008546842A (ja) * 2005-06-27 2008-12-25 エドワード ヴィア バージニア カレッジ オブ オステオパシック メディスン 酸化セリウムナノ粒子の抗炎症性、放射線防護性および寿命促進能
US10857178B2 (en) * 2005-06-27 2020-12-08 Edward Via Virginia College Of Osteopathic Medicine Cerium oxide nanoparticles for treatment and prevention of Alzheimer's disease, Parkinson's disease, and disorders associated with free radical production and/or mitochondrial dysfunction
US9649337B2 (en) 2005-06-27 2017-05-16 Edward Via Virginia College Of Osteopathic Medicine Cerium oxide nanoparticles for the treatment and prevention of stroke and cardiovascular disease
US7959949B2 (en) 2006-04-27 2011-06-14 University Of Central Florida Research Foundation, Inc. Functionalized nanoceria composition for ophthalmic treatment
WO2008064357A2 (en) * 2006-11-22 2008-05-29 University Of Florida Research Foundation, Inc. Nanoparticles for protection of cells from oxidative stress
US20080166412A1 (en) * 2007-01-02 2008-07-10 Kiminobu Sugaya Methods and materials for stimulating proliferation of stem cell
US9119391B1 (en) 2007-07-16 2015-09-01 University Of Central Florida Research Foundation, Inc. Polymer coated ceria nanoparticles for selective cytoprotection
US8916199B1 (en) 2008-04-25 2014-12-23 University of Central Florida Research Foundation, Ind. Inhibition of angiogenesis associated with ovarian cancer by nanoparticles of cerium oxide
EP2288258A4 (de) * 2008-04-25 2012-10-31 Univ Oklahoma Inhibition of neovascularization by cerium oxide nanoparticles
US9207385B2 (en) 2008-05-06 2015-12-08 Qd Vision, Inc. Lighting systems and devices including same
WO2009151515A1 (en) 2008-05-06 2009-12-17 Qd Vision, Inc. Solid state lighting devices including quantum confined semiconductor nanoparticles
US9127202B1 (en) 2008-07-18 2015-09-08 University Of Central Florida Research Foundation, Inc. Biocompatible nano rare earth oxide upconverters for imaging and therapeutics
US20100098768A1 (en) * 2008-10-16 2010-04-22 Clarkson University Method of neuroprotection from oxidant injury using metal oxide nanoparticles
US8883519B1 (en) 2009-03-17 2014-11-11 University Of Central Florida Research Foundation, Inc. Oxidase activity of polymeric coated cerium oxide nanoparticles
WO2010129374A2 (en) 2009-04-28 2010-11-11 Qd Vision, Inc. Optical materials, optical components, and methods
US9585840B1 (en) 2009-07-10 2017-03-07 University Of Central Florida Research Foundation, Inc. Redox active cerium oxide nanoparticles and associated methods
US8795731B1 (en) 2009-10-12 2014-08-05 University Of Central Florida Research Foundation, Inc. Cerium oxide nanoparticle-based device for the detection of reactive oxygen species and monitoring of chronic inflammation
US8877207B2 (en) 2010-09-17 2014-11-04 University Of Central Florida Research Foundation, Inc. Nanoparticles of cerium oxide targeted to an amyloid-beta antigen of Alzheimer's disease and associated methods
US11116792B1 (en) 2010-12-22 2021-09-14 Biocurity Holdings, Inc. Cerium oxide nanoparticle formulation for use in skin radioprotection and associated methods
US8951539B1 (en) 2011-06-07 2015-02-10 University Of Central Florida Research Foundation, Inc. Methods of promoting angiogenesis using cerium oxide nanoparticles
US9161950B2 (en) 2011-09-21 2015-10-20 University Of Central Florida Foundation, Inc. Neuronal protection by cerium oxide nanoparticles
US9415065B2 (en) 2012-04-04 2016-08-16 University Of Central Florida Research Foundation, Inc. Methods of using cerium oxide nanoparticles to mitigate or protect against radiation injury
US9463437B2 (en) 2013-02-14 2016-10-11 University Of Central Florida Research Foundation, Inc. Methods for scavenging nitric oxide using cerium oxide nanoparticles
US9669055B1 (en) 2014-04-11 2017-06-06 Marshall University Research Corporation Methods for treating sepsis
US11389536B2 (en) 2015-07-17 2022-07-19 BioCurity Pharmaceuticals Inc. Treatment of cancer with a combination of radiation, cerium oxide nanoparticles, and a chemotherapeutic agent
CN108685847A (zh) * 2018-06-29 2018-10-23 温州医科大学 一种针对氧化损伤诱导炎症的长效抗炎眼用分散制剂
EP4074319A1 (de) 2021-04-15 2022-10-19 Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca Ophthalmische topische zusammensetzung mit ceroxid-nanoteilchen zur behandlung von erkrankungen des hinteren augensegments

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US676043A (en) 1899-11-22 1901-06-11 John C Lincoln Electric drill.
US716630A (en) 1902-03-24 1902-12-23 August Eimer Crucible.
US6291506B1 (en) * 1998-08-04 2001-09-18 Wisconsin Alumni Research Foundation Method of reducing retinal ganglion cell degeneration
WO2000035415A1 (de) * 1998-12-11 2000-06-22 Cognis Deutschland Gmbh Verwendung von nanoskaligen organischen uv-lichtschutzfiltern
US7930285B2 (en) * 2000-03-22 2011-04-19 Comscore, Inc. Systems for and methods of user demographic reporting usable for identifying users and collecting usage data
FR2809637B1 (fr) * 2000-06-05 2003-01-24 Rhodia Terres Rares Dispersion colloidale d'un compose de cerium ou d'un compose de cerium et d'au moins un autre element choisi parmi les terres rares et des metaux de transition et comprenant un acide amine
CN1189505C (zh) * 2000-07-05 2005-02-16 日本Arc株式会社 透明层压体、眼镜用塑料镜片和底涂剂组合物
WO2003059193A2 (en) * 2001-12-21 2003-07-24 Alcon, Inc. Use of nanoparticles as carriers for biocides in ophthalmic compositions
US7431758B2 (en) * 2002-10-28 2008-10-07 Nissan Chemical Industries, Ltd. Cerium oxide particles and production method therefor
WO2004096146A2 (en) * 2003-04-25 2004-11-11 Nolan Gerard M Method and composition for preventing, reducing and reversing ocular ischemic neuronal damage

Also Published As

Publication number Publication date
US20060246152A1 (en) 2006-11-02
ATE482748T1 (de) 2010-10-15
WO2006118954A8 (en) 2007-08-23
EP2359907A1 (de) 2011-08-24
WO2006118954A3 (en) 2007-05-24
US7347987B2 (en) 2008-03-25
EP1879570B1 (de) 2010-09-29
AU2006242541B2 (en) 2011-12-08
CA2610296C (en) 2016-06-14
WO2006118954A2 (en) 2006-11-09
EP1879570A4 (de) 2008-10-01
US20070202193A1 (en) 2007-08-30
CA2610296A1 (en) 2006-11-09
AU2006242541A1 (en) 2006-11-09
EP1879570A2 (de) 2008-01-23
US7727559B2 (en) 2010-06-01

Similar Documents

Publication Publication Date Title
DE602006017199D1 (de) Hemmung reaktiver sauerstoffspezies und schutz von säugerzellen
Xiao et al. The water-soluble fullerene derivative ‘Radical Sponge®’exerts cytoprotective action against UVA irradiation but not visible-light-catalyzed cytotoxicity in human skin keratinocytes
Yin et al. Antimicrobial photosensitizers: drug discovery under the spotlight
Sun et al. Nanoparticles having amphiphilic silane containing Chlorin e6 with strong anti-biofilm activity against periodontitis-related pathogens
Peng et al. Natural organic matter–induced alleviation of the phytotoxicity to rice (Oryza sativa L.) caused by copper oxide nanoparticles
Yang et al. Carbon‐Dot‐Decorated TiO2 Nanotubes toward Photodynamic Therapy Based on Water‐Splitting Mechanism
MX343075B (es) Composiciones y metodos fotoactivables que desprenden oxigeno para el blanqueamiento dental.
ATE547107T1 (de) Verwendung von selenhefe in der behandlung von alzheimers krankheit
FR2964663B1 (fr) Composition cosmetique comprenant une matiere colorante, ladite matiere colorante et procede de traitement cosmetique
NO20073780L (no) Nanopartikulaere kandesartan-formuleringer
Li et al. Personalized medicine: cell and gene therapy based on patient-specific iPSC-derived retinal pigment epithelium cells
Cardillo et al. Attenuation of UV absorption by poly (lactic acid)-iron oxide nanocomposite particles and their potential application in sunscreens
Peloi et al. Antioxidative photochemoprotector effects of cerium oxide nanoparticles on UVB irradiated fibroblast cells
ES2431188T3 (es) Composiciones fluidas aptas para formar un revestimiento que presenta propiedades antivirales
Zhang et al. MnO 2-capped silk fibroin (SF) nanoparticles with chlorin e6 (Ce6) encapsulation for augmented photo-driven therapy by modulating the tumor microenvironment
WO2006138421A3 (en) Nanoparticulate azelnidipine formulations
JP2012097020A (ja) 一重項酸素の消去方法
EA200800092A1 (ru) Композиции в виде наночастиц и с контролируемым высвобождением, включающие арил-гетероциклические соединения
Erdinç Graphene on dentistry: A bibliometric and scientometric analysis
ATE505182T1 (de) Stabilisierte und konservierte ketotifen enthaltende ophthalmologische zusammensetzungen
Shi et al. Mechanism of N‑acetyl‑cysteine inhibition on the cytotoxicity induced by titanium dioxide nanoparticles in JB6 cells transfected with activator protein‑1
Wu et al. Biodegradable copper peroxide decorated hollow polydopamine nanocomposite as effective chloroperoxidase delivery carrier for enhancing enzyme dynamic therapy via self-activated cascade reactions
Mahesh et al. Highly efficient strategy for photocatalytic tooth bleaching using SiO2/MgO/Fe2O3 nanocomposite spheres
Balkan et al. Antioxidant Enzyme Activities in Ascorbic Acid and Selenium Applied Hepatocellular Carcinoma Cells
Kury et al. Novel Experimental In-Office Bleaching Gels Containing Co-Doped Titanium Dioxide Nanoparticles. Nanomaterials 2022, 12, 2995